Please use this identifier to cite or link to this item: https://repository.seku.ac.ke/handle/123456789/682
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKanui, Titus I.-
dc.contributor.authorTjølsen, A.-
dc.contributor.authorLund, A.-
dc.contributor.authorMjellem-Joly, N.-
dc.contributor.authorHole, K.-
dc.date.accessioned2015-01-21T09:28:47Z-
dc.date.available2015-01-21T09:28:47Z-
dc.date.issued1993-04-
dc.identifier.citationNeuropharmacology. 1993 Apr;32(4):367-71en_US
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/8098863-
dc.identifier.urihttp://hdl.handle.net/123456789/682-
dc.description.abstractThe hypothesis that the descending noradrenergic system tonically inhibits nociception at the spinal level was investigated, using the formalin test in mice. The alpha-adrenoceptor agonist clonidine (0.46 and 0.92 microgram), injected intrathecally, significantly reduced licking activity in both the early and late phase of the test. The alpha 1-antagonist prazosin (3.75, 7.5 and 15 micrograms) and the alpha 2-antagonist yohimbine (7.5 micrograms) also significantly reduced licking activity in both phases. The smaller doses of yohimbine (1.87 and 3.75 micrograms) induced an insignificant reduction of licking in the early phase. Except for the largest doses of clonidine (0.92 microgram), the drugs used had no effect on the general level of activity and motor performance. These results support previous findings that increased noradrenergic activity in the spinal cord inhibits nociception, however, this inhibition seems not to be tonically active. The mechanisms of the antinociceptive actions of alpha-antagonists are not clear.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.titleAntinociceptive effects of intrathecal administration of alpha-adrenoceptor antagonists and clonidine in the formalin test in the mouseen_US
dc.typeArticleen_US
Appears in Collections:School of Agriculture, Environment, Water and Natural Resources Management (JA)



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.